David J. Schlanger - Apr 21, 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Executive Chairman, Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Apr 21, 2023
Transactions value $
-$1,620,330
Form type
4
Date filed
4/25/2023, 04:58 PM
Previous filing
Apr 5, 2023
Next filing
May 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $33.9K +37.3K +50.75% $0.91* 111K Apr 21, 2023 Direct
transaction PGNY Common Stock Sale -$1.31M -37.3K -33.67% $35.01 73.5K Apr 21, 2023 Direct F1, F2
transaction PGNY Common Stock Options Exercise $9.3K +10.2K +13.91% $0.91* 83.7K Apr 24, 2023 Direct
transaction PGNY Common Stock Sale -$358K -10.2K -12.21% $35.00 73.5K Apr 24, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -37.3K -5.09% $0.00 695K Apr 21, 2023 Common Stock 37.3K $0.91 Direct F4
transaction PGNY Stock Option (Right to Buy) Options Exercise $0 -10.2K -1.47% $0.00 685K Apr 24, 2023 Common Stock 10.2K $0.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
F4 These options are fully vested and exercisable.